373 related articles for article (PubMed ID: 17123268)
1. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.
Mesa RA; Niblack J; Wadleigh M; Verstovsek S; Camoriano J; Barnes S; Tan AD; Atherton PJ; Sloan JA; Tefferi A
Cancer; 2007 Jan; 109(1):68-76. PubMed ID: 17123268
[TBL] [Abstract][Full Text] [Related]
2. The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.
Geyer HL; Andreasson B; Kosiorek HE; Dueck AC; Scherber RM; Martin KA; Butler KA; Harrison CN; Radia DH; Cervantes F; Kiladjian JJ; Reiter A; Birgegard G; Passamonti F; Senyak Z; Vannucchi AM; Paoli C; Xiao Z; Samuelsson J; Mesa RA
Cancer; 2016 Jun; 122(12):1888-96. PubMed ID: 27070130
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension associated with myeloproliferative disorders: a retrospective study of ten cases.
Guilpain P; Montani D; Damaj G; Achouh L; Lefrère F; Le Pavec J; Marfaing-Koka A; Dartevelle P; Simonneau G; Humbert M; Hermine O
Respiration; 2008; 76(3):295-302. PubMed ID: 18160817
[TBL] [Abstract][Full Text] [Related]
4. Patterns of objective physical functioning and perception of mood and fatigue in posttreatment breast cancer patients and healthy controls: an ambulatory psychophysiological investigation.
Grossman P; Deuring G; Garland SN; Campbell TS; Carlson LE
Psychosom Med; 2008 Sep; 70(7):819-28. PubMed ID: 18725433
[TBL] [Abstract][Full Text] [Related]
5. Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease.
Blinderman CD; Homel P; Billings JA; Tennstedt S; Portenoy RK
J Pain Symptom Manage; 2009 Jul; 38(1):115-23. PubMed ID: 19232893
[TBL] [Abstract][Full Text] [Related]
6. Fatigue after traumatic brain injury and its impact on participation and quality of life.
Cantor JB; Ashman T; Gordon W; Ginsberg A; Engmann C; Egan M; Spielman L; Dijkers M; Flanagan S
J Head Trauma Rehabil; 2008; 23(1):41-51. PubMed ID: 18219234
[TBL] [Abstract][Full Text] [Related]
7. Comprehensively understanding fatigue in patients with myeloproliferative neoplasms.
Scherber RM; Kosiorek HE; Senyak Z; Dueck AC; Clark MM; Boxer MA; Geyer HL; McCallister A; Cotter M; Van Husen B; Harrison CN; Mesa RA
Cancer; 2016 Feb; 122(3):477-85. PubMed ID: 26670597
[TBL] [Abstract][Full Text] [Related]
8. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
[TBL] [Abstract][Full Text] [Related]
9. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in short-bowel syndrome: impact of fatigue and gastrointestinal symptoms.
Kalaitzakis E; Carlsson E; Josefsson A; Bosaeus I
Scand J Gastroenterol; 2008; 43(9):1057-65. PubMed ID: 18609190
[TBL] [Abstract][Full Text] [Related]
11. Long-term pain, fatigue, and impairment in neuralgic amyotrophy.
van Alfen N; van der Werf SP; van Engelen BG
Arch Phys Med Rehabil; 2009 Mar; 90(3):435-9. PubMed ID: 19254608
[TBL] [Abstract][Full Text] [Related]
12. Exploring determinants for quality of life among older people in pain and in need of help for daily living.
Jakobsson U; Hallberg IR; Westergren A
J Clin Nurs; 2007 Mar; 16(3A):95-104. PubMed ID: 17518874
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life, physical function, fatigue, and disease activity in children with established polyarticular juvenile idiopathic arthritis.
Ringold S; Wallace CA; Rivara FP
J Rheumatol; 2009 Jun; 36(6):1330-6. PubMed ID: 19411394
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument.
Evers AW; Duller P; van de Kerkhof PC; van der Valk PG; de Jong EM; Gerritsen MJ; Otero E; Verhoeven EW; Verhaak CM; Kraaimaat FW
Br J Dermatol; 2008 Jan; 158(1):101-8. PubMed ID: 17999699
[TBL] [Abstract][Full Text] [Related]
15. Functional incapacity and physical and psychological symptoms: how they interconnect in chronic fatigue syndrome.
Priebe S; Fakhoury WK; Henningsen P
Psychopathology; 2008; 41(6):339-45. PubMed ID: 18765959
[TBL] [Abstract][Full Text] [Related]
16. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
Kalkman JS; Schillings ML; Zwarts MJ; van Engelen BG; Bleijenberg G
J Psychosom Res; 2007 May; 62(5):571-9. PubMed ID: 17467412
[TBL] [Abstract][Full Text] [Related]
17. Association of comorbid mood disorders and chronic illness with disability and quality of life in Ontario, Canada.
Gadalla T
Chronic Dis Can; 2008; 28(4):148-54. PubMed ID: 18625088
[TBL] [Abstract][Full Text] [Related]
18. The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS.
Coyne KS; Wein AJ; Tubaro A; Sexton CC; Thompson CL; Kopp ZS; Aiyer LP
BJU Int; 2009 Apr; 103 Suppl 3():4-11. PubMed ID: 19302497
[TBL] [Abstract][Full Text] [Related]
19. Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: results of a survey of 985 patients.
Berti D; Moons P; Dobbels F; Deuson R; Janssens A; De Geest S
Clin Ther; 2008 Aug; 30(8):1540-52. PubMed ID: 18803995
[TBL] [Abstract][Full Text] [Related]
20. The role of beta-catenin in chronic myeloproliferative disorders.
Jauregui MP; Sanchez SR; Ewton AA; Rice L; Perkins SL; Dunphy CH; Chang CC
Hum Pathol; 2008 Oct; 39(10):1454-8. PubMed ID: 18619646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
